AMANDA PLETZ: Open Payments
NPI 1134538937 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 43 payments from 18 companies in 2025. Trend: 2023 $872 · 2024 $968 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $95 |
| Lilly USA, LLC | 6 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| PFIZER INC. | 5 | $86 |
| Exact Sciences Corporation | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: JARDIANCE, Cologuard Collection Kit, QULIPTA, MOUNJARO, GLASSIA, PREVNAR 20, Veozah, CAPLYTA.
Industry payments across PA — which companies pay providers there.
